SECONAL SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Seconal Sodium, and when can generic versions of Seconal Sodium launch?
Seconal Sodium is a drug marketed by Valeant Pharms North and Lilly and is included in three NDAs.
The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Additional details are available on the secobarbital sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SECONAL SODIUM?
- What are the global sales for SECONAL SODIUM?
- What is Average Wholesale Price for SECONAL SODIUM?
Summary for SECONAL SODIUM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Patent Applications: | 101 |
| DailyMed Link: | SECONAL SODIUM at DailyMed |
US Patents and Regulatory Information for SECONAL SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms North | SECONAL SODIUM | secobarbital sodium | CAPSULE;ORAL | 086101-001 | Oct 3, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | SECONAL SODIUM | secobarbital sodium | SUPPOSITORY;RECTAL | 086530-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | SECONAL SODIUM | secobarbital sodium | SUPPOSITORY;RECTAL | 086530-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
